{"id":"https://openalex.org/W4241361444","doi":"https://doi.org/10.1210/endo-meetings.2010.part2.p1.p2-12","title":"Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists for the Treatment of Cutaneous T-Cell Lymphoma.","display_name":"Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists for the Treatment of Cutaneous T-Cell Lymphoma.","publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W4241361444","doi":"https://doi.org/10.1210/endo-meetings.2010.part2.p1.p2-12"},"language":"en","primary_location":{"id":"doi:10.1210/endo-meetings.2010.part2.p1.p2-12","doi":"https://doi.org/10.1210/endo-meetings.2010.part2.p1.p2-12","is_oa":false,"landing_page_url":"http://doi.org/10.1210/endo-meetings.2010.part2.p1.p2-12","pdf_url":null,"source":{"id":"https://openalex.org/S4363604889","display_name":"The Endocrine Society's 92nd Annual Meeting, June 19\u201322, 2010 - San Diego","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Endocrine Society's 92nd Annual Meeting, June 19\u201322, 2010 - San Diego","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026186126","display_name":"J.K. Furmick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JK Furmick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091460152","display_name":"CE Wagner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CE Wagner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009255117","display_name":"A van der Vaar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A van der Vaar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029629837","display_name":"S.L. Badshah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SL Badshah","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"PA Marshall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PA Marshall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046892542","display_name":"Peter W. Jurutka","orcid":"https://orcid.org/0000-0002-4950-9161","observed_orcids":["https://orcid.org/0000-0002-4950-9161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PW Jurutka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.65204387,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"P2","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.6499000191688538,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.6499000191688538,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0820000022649765,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.07699999958276749,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/retinoid-x-receptor","display_name":"retinoid X receptor","score":0.9810000061988831},{"id":"https://openalex.org/keywords/rxr-agonists","display_name":"RXR agonists","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.8980000019073486},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.6470000147819519},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.671999990940094},{"id":"https://openalex.org/keywords/biological-evaluation","display_name":"biological evaluation","score":0.44699999690055847},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C128821507","wikidata":"https://www.wikidata.org/wiki/Q3454518","display_name":"Retinoid X receptor","level":5,"score":0.822104811668396},{"id":"https://openalex.org/C2778820923","wikidata":"https://www.wikidata.org/wiki/Q418192","display_name":"Bexarotene","level":5,"score":0.6394942402839661},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.5696716904640198},{"id":"https://openalex.org/C758759","wikidata":"https://www.wikidata.org/wiki/Q18031337","display_name":"Retinoid X receptor beta","level":5,"score":0.5148748159408569},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4953669309616089},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47248879075050354},{"id":"https://openalex.org/C68484354","wikidata":"https://www.wikidata.org/wiki/Q17516011","display_name":"Retinoid X receptor alpha","level":5,"score":0.46315422654151917},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4149162173271179},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3943086862564087},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34339356422424316},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34093958139419556},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2947160601615906},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2944982349872589},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20424655079841614},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.19108682870864868},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.17477020621299744},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.06263461709022522},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.052188485860824585}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1210/endo-meetings.2010.part2.p1.p2-12","doi":"https://doi.org/10.1210/endo-meetings.2010.part2.p1.p2-12","is_oa":false,"landing_page_url":"http://doi.org/10.1210/endo-meetings.2010.part2.p1.p2-12","pdf_url":null,"source":{"id":"https://openalex.org/S4363604889","display_name":"The Endocrine Society's 92nd Annual Meeting, June 19\u201322, 2010 - San Diego","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Endocrine Society's 92nd Annual Meeting, June 19\u201322, 2010 - San Diego","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Zero hunger","score":0.46000000834465027,"id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412516754","https://openalex.org/W2039126303","https://openalex.org/W3169096751","https://openalex.org/W2017859957","https://openalex.org/W2509131705","https://openalex.org/W4313147566","https://openalex.org/W2149059361","https://openalex.org/W1999740475","https://openalex.org/W2947312515","https://openalex.org/W2342785416"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-05-12T00:00:00"}